Table 2 Response and Survival
Docetaxel/Oxaliplatin (n = 44) | ||
|---|---|---|
Efficacy | Number of Patients | Percent |
Response | ||
Complete response (CR) | 0 | |
Partial response (PR) | 7 | 15.9 |
Stable disease (SD) | 14 | 31.8 |
Progressive disease (PD) | 23 | 52.3 |
Disease control rate (CR + PR + SD) | 21 | 47.7 |
Survival | months | 95 % CI |
Median progression free survival | 1.82 | 1.5–3.96 |
Median overall survival | 10.1 | 5.1–14.1 |